drugset
drugset / Trial / NCT04768868

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

NCT04768868 ↗

Phase 1 Unknown 350 enrolled Impact Therapeutics, Inc. Covance · collab
NaSequentialOpen-labelTreatment

Summary

A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors

Timeline

Start
2021-02-25
Primary completion
2023-04-30
Completion
2023-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject IMP7068 Unknown — —

Indications

cancer